These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 17379101)
21. Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment. Mitsiades CS; Mitsiades NS; Richardson PG; Munshi NC; Anderson KC J Cell Biochem; 2007 Jul; 101(4):950-68. PubMed ID: 17546631 [TBL] [Abstract][Full Text] [Related]
22. Estrogenic or antiestrogenic therapies for multiple myeloma? Sola B; Renoir JM Mol Cancer; 2007 Sep; 6():59. PubMed ID: 17888187 [TBL] [Abstract][Full Text] [Related]
28. Melphalan and its role in the management of patients with multiple myeloma. Falco P; Bringhen S; Avonto I; Gay F; Morabito F; Boccadoro M; Palumbo A Expert Rev Anticancer Ther; 2007 Jul; 7(7):945-57. PubMed ID: 17627453 [TBL] [Abstract][Full Text] [Related]
29. The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma. Dmoszynska A; Podhorecka M; Manko J; Bojarska-Junak A; Rolinski J; Skomra D Neoplasma; 2005; 52(2):175-81. PubMed ID: 15800717 [TBL] [Abstract][Full Text] [Related]
30. Overcoming drug resistance in multiple myeloma: the emergence of therapeutic approaches to induce apoptosis. Yang HH; Ma MH; Vescio RA; Berenson JR J Clin Oncol; 2003 Nov; 21(22):4239-47. PubMed ID: 14615454 [TBL] [Abstract][Full Text] [Related]
31. Towards a new age in the treatment of multiple myeloma. Piazza FA; Gurrieri C; Trentin L; Semenzato G Ann Hematol; 2007 Mar; 86(3):159-72. PubMed ID: 17205287 [TBL] [Abstract][Full Text] [Related]
32. Treatment of multiple myeloma in the targeted therapy era. Saad AA; Sharma M; Higa GM Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585 [TBL] [Abstract][Full Text] [Related]
33. Emerging strategies for targeting cell adhesion in multiple myeloma. Nair RR; Gebhard AW; Emmons MF; Hazlehurst LA Adv Pharmacol; 2012; 65():143-89. PubMed ID: 22959026 [TBL] [Abstract][Full Text] [Related]
34. Cytokines and signal transduction. Hideshima T; Podar K; Chauhan D; Anderson KC Best Pract Res Clin Haematol; 2005; 18(4):509-24. PubMed ID: 16026734 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells. Hideshima T; Catley L; Raje N; Chauhan D; Podar K; Mitsiades C; Tai YT; Vallet S; Kiziltepe T; Ocio E; Ikeda H; Okawa Y; Hideshima H; Munshi NC; Yasui H; Richardson PG; Anderson KC Br J Haematol; 2007 Sep; 138(6):783-91. PubMed ID: 17760810 [TBL] [Abstract][Full Text] [Related]